These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21498781)

  • 1. Cigarette smoking and prostate cancer recurrence after prostatectomy.
    Joshu CE; Mondul AM; Meinhold CL; Humphreys EB; Han M; Walsh PC; Platz EA
    J Natl Cancer Inst; 2011 May; 103(10):835-8. PubMed ID: 21498781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking history, intensity, and duration and risk of prostate cancer recurrence among men with prostate cancer who received definitive treatment.
    Khan S; Thakkar S; Drake B
    Ann Epidemiol; 2019 Oct; 38():4-10. PubMed ID: 31563295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
    Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
    Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group.
    Teeter AE; Griffin K; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
    J Urol; 2018 Mar; 199(3):713-718. PubMed ID: 28870860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Boffetta P; Freedland SJ
    Cancer; 2014 Jan; 120(2):197-204. PubMed ID: 24127391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and prostate cancer survival and recurrence.
    Kenfield SA; Stampfer MJ; Chan JM; Giovannucci E
    JAMA; 2011 Jun; 305(24):2548-55. PubMed ID: 21693743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Antonelli JA; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Urology; 2010 Nov; 76(5):1218-23. PubMed ID: 20381838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
    Partin AW; Pearson JD; Landis PK; Carter HB; Pound CR; Clemens JQ; Epstein JI; Walsh PC
    Urology; 1994 May; 43(5):649-59. PubMed ID: 7513108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and adverse outcomes at radical prostatectomy.
    Ngo TC; Lee JJ; Brooks JD; Nolley R; Ferrari M; Presti JC
    Urol Oncol; 2013 Aug; 31(6):749-54. PubMed ID: 21824793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer biochemical recurrence rates after robotic-assisted laparoscopic radical prostatectomy.
    Ginzburg S; Nevers T; Staff I; Tortora J; Champagne A; Kesler SS; Laudone VP; Wagner JR
    JSLS; 2012; 16(3):443-50. PubMed ID: 23318071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
    D'Amico AV; Moul JW; Carroll PR; Sun L; Lubeck D; Chen MH
    J Natl Cancer Inst; 2003 Sep; 95(18):1376-83. PubMed ID: 13130113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
    Zapata DF; Howard LE; Aronson WJ; Kane CJ; Terris MK; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2015 Jul; 22(7):658-62. PubMed ID: 25872110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population.
    Inoue T; Kinoshita H; Terada N; Kobayashi T; Yamasaki T; Matsui Y; Kamba T; Inui H; Sugi M; Matsuda T; Ogawa O
    Jpn J Clin Oncol; 2015 Aug; 45(8):780-4. PubMed ID: 25981623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
    Liesenfeld L; Kron M; Gschwend JE; Herkommer K
    J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
    Cooperberg MR; Pasta DJ; Elkin EP; Litwin MS; Latini DM; Du Chane J; Carroll PR
    J Urol; 2005 Jun; 173(6):1938-42. PubMed ID: 15879786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.
    Mandel P; Oh SJ; Hagner C; Tennstedt P; Kriegmair MC; Huland H; Graefen M; Tilki D
    World J Urol; 2016 Nov; 34(11):1547-1553. PubMed ID: 27003277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.